Evidence map›Paper›PMID 40918883›Full record

ReviewCureus2025

Electronic Cigarette Use (Vaping) Among Adolescents: A Narrative Review of an Emerging Public Health Epidemic.

Arshia Khodaee, Alex Reed, Morteza Khodaee

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Smoke Returns in Disguise.Open respiratory archives
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Arshia KhodaeeBiology, University of Wisconsin-Madison, Madison, USA.
Alex ReedFamily Medicine, University of Colorado School of Medicine, Denver, USA.
Morteza KhodaeeSports Medicine, University of Colorado School of Medicine, Denver, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current electronic cigarette (e-cigarette) format was made known to the public in recent decades. Since then, it has gained widespread popularity, particularly among adolescents. A significant portion of young people in the United States and around the world are reported to use e-cigarettes. The reasons for its popularity might be related to its many enticing flavors and being rechargeable. There are many different delivery systems and devices used for e-cigarettes. It took some time for governing organizations, such as the United States Food and Drug Administration (FDA), to place limitations and regulations on the distribution, advertisement, and easy access by minors. E-cigarettes have been advertised as a safer version of the typical (combustible) cigarettes. Nicotine is the main ingredient of most e-cigarettes. Small amounts of other chemicals, including heavy metals and known carcinogens, have also been detected. Evidence of the harmful nature of e-cigarettes is emerging and alarming. Short-term health effects of e-cigarette use may include oral, respiratory, and cardiac illnesses. Long-term outcomes of e-cigarette use, particularly among adolescents, are unknown. E-cigarettes may help with smoking cessation in adults, but their benefits among adolescents are lacking. The purpose of this narrative review is to summarize the risk factors and discuss potential complications associated with adolescent e-cigarette usage. We will also discuss the evidence for concurrent use of other legal and illegal substances with e-cigarettes. Evidence for the most effective ways for cessation is lacking, and further research is needed.

Indexed as

addictionbehavioral healthnicotinetobaccovaping devices

Identifiers

PMID40918883
PMCPMC12410507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.